Anthony S. Gibney - 15 Apr 2024 Form 3 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
15 Apr 2024
Net transactions value
$0
Form type
3
Filing time
16 Apr 2024, 16:30:33 UTC
Previous filing
13 Jul 2023
Next filing
19 Apr 2024

No securities are beneficially owned.